PFE today
$28.83-$0.62 (-2.11%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourAscending Triangle
15 minLeaning Bullish
5 minBearish
Daily trend turns down below $27.12
Key levels
Resistance$30.69
Resistance$29.88
Support$28.54
Support$27.12
Latest news & SEC filings
DealBlackstone to fund Pfizer obesity treatment studies for share of later revenue
DealPfizer holds 1.857M shares of Wave Life Sciences after new position
DealPfizer and Blackstone Life Sciences sign funding deal for obesity program
DealPfizer and Blackstone Life Sciences agree co-funding deal for berobenatide study
AnalystDaiwa Securities Changes Its Rating and Target on Pfizer
All PFE news →About Pfizer
Pfizer is a research-based pharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines. Its portfolio spans therapeutic areas including oncology, internal medicine, vaccines, inflammation and immunology, and antivirals, sold to wholesalers, pharmacies, hospitals, governments, and healthcare providers. The company operates worldwide, with significant business in the United States, Europe, and Asia Pacific, and also markets biosimilar products.
Based on the company's 10-K filed Feb 26, 2026.
NYSE · Healthcare
PFIZER INC (PFE)
What Is the Price Target for PFE?
SEPT Low Target
$26.00
SEPT Mid Target
$30.00
SEPT High Target
$35.00
Analyst Consensus
$30.00
Is PFE a Buy or Sell Right Now?
Thesis
- •Revenue growing -1.6% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PFE.
Start Free Trial →Is PFE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$35.25
30
Moat Score
NONE
5/9
Piotroski Score
1.9
Altman Z-Score
What Is Smart Money Doing with PFE?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
BUYING
12 buys / 8 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| DAMICO JENNIFER B. | officer | Sale | 3,278 | $83K | Aug 5, 2026 |
| DAMICO JENNIFER B. | officer | Sale | 2,000 | $51K | Jun 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PFE Growth Story
Revenue YoY
-1.6%
3yr Revenue CAGR
-14.8%
EPS Growth YoY
-3.55%
FCF Growth YoY
-7.7%
Revenue Trend
ACCELERATING
Dark Pool Trades for PFE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PFE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:24:32 | $29.14 | 2,442 | $$71K | BUY |
| 18:24:26 | $29.15 | 1,300 | $$38K | BUY |
| 18:24:23 | $29.14 | 1,000 | $$29K | BUY |
| 18:24:20 | $29.14 | 1,983 | $$58K | MIDPOINT |
| 18:24:14 | $29.14 | 1,000 | $$29K | MIDPOINT |
5 dark pool trades shown · $$225K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PFE
PREVIEWSEPT Investing provides real-time options flow tracking for PFE, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $29 | Nov 27 | 15 | $$45 | 1 | SWEEP |
| PUT | $29 | Nov 27 | 15 | $$135 | 3 | SWEEP |
| PUT | $29 | Nov 27 | 15 | $$315 | 7 | SWEEP |
| PUT | $29 | Nov 27 | 15 | $$225 | 5 | SWEEP |
| PUT | $29 | Nov 27 | 15 | $$270 | 6 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PFIZER INC (PFE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PFE — frequently asked questions
What is PFE stock price today?
PFIZER INC (PFE) is at $28.83, down 2.11% (-$0.62) at the Nov 12, 2026 close.
Why is PFE stock moving today?
Latest PFE news — Nov 12, 2026: Blackstone to fund Pfizer obesity treatment studies for share of later revenue · Nov 12, 2026: Pfizer holds 1.857M shares of Wave Life Sciences after new position
Why did PFE stock move on Nov 3, 2026?
Pfizer shares fell 2.22% to close at $30.00 despite reporting better-than-expected third-quarter earnings and raising its full-year guidance, with the company citing growth in its non-COVID portfolio. The stock traded between a low of $29.89 and a high of $31.06 on heavy volume of over 40 million shares.
What is the PFE price target?
The average analyst price target for PFE is $30.00, ranging from $26 to $35, based on 13 analysts. Latest: Freedom Broker raises on Nov 6, 2026.
What do analysts rate PFE?
Analyst ratings for PFE: 0 Buy, 22 Hold, 1 Sell — consensus Hold.
Did PFE beat earnings?
PFE last reported on Nov 3, 2026: EPS $0.56 vs $0.73 expected — a miss of 23.8%.
What is PFE's P/E ratio?
PFE trades at a P/E of 41.9 vs a Healthcare average of 17.2.
Does PFE pay a dividend?
Yes. PFE's dividend yield is 6.91%.
What are PFE support and resistance levels?
Support: $28.54, $27.12, $26.18. Resistance: $29.88, $30.69, $31.44.
What are insiders doing with PFE?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on PFE?
Nov 12, 2026: Blackstone to fund Pfizer obesity treatment studies for share of later revenue · Nov 12, 2026: Pfizer holds 1.857M shares of Wave Life Sciences after new position · Nov 11, 2026: Pfizer and Blackstone Life Sciences sign funding deal for obesity program